Clearity Foundation

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies

Jeffrey S. Ross, Siraj M. Ali, K. Wang et al. · Gynecologic Oncology · 2013 · 90 citations

Medicine, Genetics, Oncology +17

Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type

Douglas I. Lin, Yakov Chudnovsky, Bridget Duggan et al. · Gynecologic Oncology · 2017 · 53 citations

Medicine, Genetics, Oncology +16

Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies

Stéphanie Gaillard, Kaitlyn J. Andreano, Laurie M. Gay et al. · Gynecologic Oncology · 2019 · 44 citations

Medicine, Gynecology, Oncology +17

Treatment-Related Protein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas

Deborah A. Zajchowski, Beth Y. Karlan, Laura K. Shawver · Molecular Cancer Therapeutics · 2011 · 28 citations

Medicine, Oncology, Pathology +17

Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease

Michael Castro, Bradford P. Whitcomb, Deborah A. Zajchowski et al. · Gynecologic Oncology Research and Practice · 2015 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17